AGP Wire

AGP

Luminari CRO said July 21, 2026, that it has appointed Jake Knorr as strategic advisor and executive relationship officer to support commercialization of its AI-powered clinical development platform, LumiPath. The hire adds a seasoned life…

AGP

RN Enterprises said Tuesday it acquired Florida-based Helping Hands Home Healthcare, a move that expands its home-based care footprint and keeps existing patients on uninterrupted service.

AGP

The pathology imaging systems market is projected to grow from $1.37 billion in 2025 to $2.29 billion by 2030, driven by AI-assisted diagnostics, cloud platforms and more clinical trials.

AGP

STK is re-entering the market with STK Helix, a 5G smartphone built for decentralized clinical trials and life sciences deployments.

AGP

The pathology imaging systems market is projected to rise from $1.37 billion in 2025 to $2.29 billion by 2030 as digital pathology, AI tools and cloud platforms expand.

AGP

Sulthanul Arif, a Data Engineering Senior Manager at Accenture and Principal AI Architect for a major U.S. healthcare organization, says an AI modernization program is delivering measurable savings and faster workflows.

AGP

Jessica Figueroa, a pharmacy leader with more than 15 years of experience, is opening a franchise-based home infusion pharmacy in West Springfield, Massachusetts.

AGP

PharmStars Ventures said June 23, 2026, that it invested in 11 startups from its Fall 2025 accelerator cohort, lifting its portfolio to 23 companies.

AGP

The Business Research Company says the global Padcev market is entering a high-growth phase, with sales projected to pass $3 billion by 2030. North America and the U.S. are expected to lead, while urothelial cancer remains the biggest use case and…

AGP

The Business Research Company says the Polivy market will exceed $5 billion in 2030, driven by wider use in diffuse large B-cell lymphoma and growing demand for antibody-drug conjugate therapies.

AGP

The Business Research Company projects the global peptide therapeutics market will pass $222 billion in 2030, driven by demand for obesity and diabetes treatments, regulatory approvals and GLP-1 research.

AGP

The Business Research Company projects the global Cytogam market will reach $0.06 billion by 2030, driven by rising transplant volumes, CMV prevention demand and broader use of immune globulin therapies.

AGP

The global market for contact centers serving pharmaceutical companies is projected to grow from $2.95 billion in 2025 to $5.1 billion by 2030, driven by clinical trial activity, biologic drugs and patient support needs.

AGP

The Business Research Company says the global fetal bovine serum market is on track to pass $1 billion by 2030, driven by rising cell culture use, biopharmaceutical R&D and research funding.

AGP

The Business Research Company says the global chimeric antibody market will cross $10 billion in 2030, driven by demand for targeted cancer immunotherapies and biologic treatments.

AGP

Aeja Jackson, PhD, an HEOR Writer at OPEN Health, is being recognized for translating complex health data into evidence that supports patient care, market access and regulatory work.

AGP

The Business Research Company says the global companion animal arthritis market will surpass $7 billion in 2030, driven by rising pet ownership, better diagnosis, and broader access to veterinary treatments.

AGP

MedTrainer ranked No. 34 among 2,452 healthcare products in G2’s 2026 Best Software Products list, a nod to the company’s healthcare compliance and credentialing platform.

AGP

A new market review says the companion animal arthritis market is moderately fragmented, with Zoetis holding the top global sales position in 2024 and the top 10 players controlling 20% of revenue.

AGP

Adalvo appointed Rannveig Borg Sigurðardóttir as chief legal officer, adding a legal leader with more than 20 years of international experience as the pharma company scales across 140-plus markets.